Clinical Trial Update: Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating antiviral therapy plus stem cell transplantation in HIV-positive patients with leukemia or lymphoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Antiviral therapy

Snippet

Sponsor: Duke University | Conditions: Leukemia, Lymphoma | Phase 1 | Status: WITHDRAWN